ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 968

What Is the Impact of Imaging on Diagnostic Ascertainment of Patients Presenting with Undiagnosed Back Pain in Routine Practice and the Impact of Central Reading? Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort

Walter P. Maksymowych1,2, Raj Carmona3, Jonathan Chan4, James Yeung5, Dianne P. Mosher6, Sibel Zehra Aydın7, Liam Martin6, Ariel Masetto8, Stephanie Keeling9, Olga Ziouzina6, Sherry Rohekar10, Joel Paschke2, Amanda Carapellucci2 and Robert G. Lambert11, 1Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, 2CaRE Arthritis, Edmonton, AB, Canada, 3St. Joseph's Health Care, Hamilton, ON, Canada, 4Artus Health Clinic, Vancouver, BC, Canada, 5James Yeung Rheumatology, Richmond, BC, Canada, 6University of Calgary, Calgary, AB, Canada, 7Ottawa Hospital, Ottawa, ON, Canada, 8Centre Hospitalier Universitaire de Sherbrooke (CHUS), Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, AB, Canada, 9Medicine, University of Alberta, Edmonton, AB, Canada, 10Western University, London, ON, Canada, 11Radiology, Radiology, University of Alberta, Edmonton, AB, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: diagnosis and spondylarthritis, Imaging, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S111 ACR Abstract: Spondyloarthritis Incl PsA–Clinical II: PsA Epidemiology (964–969)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Although MRI of the sacroiliac joints (SIJ) is the most sensitive imaging modality for early diagnosis of axial spondyloarthritis (axSpA) it is costly and not readily available. Therefore, clinicians still rely primarily on radiography. The relative degree to which radiography and MRI changes diagnostic ascertainment of axSpA in patients presenting with undiagnosed back pain has not been formally studied. We aimed to assess the relative impact of radiography and MRI evaluation on diagnostic ascertainment of axial SpA in patients presenting with undiagnosed back pain to rheumatologists, and the impact of central reading on diagnostic ascertainment.


Methods:

The multicenter Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis (SASPIC) Study is aimed at early detection of axial SpA in consecutive patients presenting with undiagnosed back pain. Consecutive patients ≤45 years of age with ≥3 months undiagnosed back pain with any one of psoriasis, acute anterior uveitis (AAU), or colitis undergo routine clinical evaluation by a rheumatologist for axial SpA and MRI evaluation is ordered per rheumatologist decision. The rheumatologist determines the presence or absence of axial SpA and the degree of confidence in the diagnosis (-10 (definitely not SpA) to +10 (definite SpA) on a numerical rating scale) at 3 consecutive stages: 1. After the clinical evaluation; 2. After the results of labs (B27, CRP) and radiography; 3. After the results of MRI evaluation. We assessed diagnostic ascertainment at each step at the categorical level (axial SpA yes/no) and also according to the degree of confidence (mean (SD) confidence). Two central readers assessed radiographs and MRI scans.


Results:

234 patients (51.3% male, mean age 34.6 years, mean symptom duration 7.0 years, mean back pain duration 7.1 years, B27+ 36.3%) were referred with AAU (29.9%), psoriasis (18.8%), Crohn’s colitis (32.1%), ulcerative colitis (19.2%). The number of patients diagnosed clinically with axSpA decreased after radiography and then decreased further after MRI while confidence in the diagnosis progressively increased (Table 1). After central reader assessment of imaging, the number of patients diagnosed with axSpA decreased substantially compared to assessment by local readers (Table 2).


Conclusion:

In a setting of undiagnosed back pain and higher risk for axial SpA, imaging is primarily helpful in ruling out SpA and reducing false positives. Despite this, central reading of imaging raises concerns regarding ascertainment of false positive SpA in routine practice.

 


Table 1

Stage of global assessment

Data source

axSpA YES, number (%),

plus mean (SD) confidence

axSpA YES with confidence >7 number (%),

plus mean (SD) confidence

axSpA NO, number (%),

plus mean (SD) confidence

axSpA NO with confidence <-4 number (%),

plus mean (SD) confidence

1. N =234

Clinical

157 (67.1%)

5.9 (2.5)

49 (20.9%)

8.8 (0.8)

77 (32.9%)

-4.4 (3.2)

39 (16.7%)

-7.1 (1.3)

2. N =234

Clinical plus radiography

132 (56.4%)

6.6 (3.0)

63 (26.9%)

9.1 (0.9)

102 (43.6%)

-6.2 (3.5)

74 (31.6%)

-7.9 (1.9)

1. N =147

Clinical

105 (71.4%)

3.5 (5.4)

25(17.0%)

7.4 (4.0)

42 (28.6%)

-2.7 (5.5)

18 (12.2%)

-4.6 (4.1)

2. N =147

Clinical plus radiography

92 (62.6%)

5.7 (3.0)

32 (21.8%)

8.8 (0.8)

55 (37.4%)

-4.9 (3.5)

35 (23.8%)

-6.9 (1.8)

3. N =147

Clinical plus radiography plus MRI

71 (48.3%)

7.4 (3.0)

44 (29.9%)

9.3 (0.8)

76 (51.7%)

-7.4 (2.6)

68 (46.3%)

-8.1 (1.6)

 

Table 2

Stage of global assessment

Data source

axSpA YES,

number (%)

axSpA NO, number (%)

2. N =212

Clinical plus radiography

120 (56.6%)

92 (43.4%)

2. N = 212

Clinical plus radiography after central reader assessment

66 (31.1%)

146 (68.9%)

3. N =128

Clinical plus radiography plus MRI

62 (48.4%)

66 (51.6%)

3. N = 128

Clinical plus radiography plus MRI after central reader assessment

39 (30.5%)

89 (69.5%)

 


Disclosure: W. P. Maksymowych, CaRE rthritis, 9; R. Carmona, None; J. Chan, AbbVie Inc., 5,Novartis, 2, 5,Pfizer, Inc., 5,UCB, Inc., 2, 5,Eli Lilly and Co., 5,Janssen, 5,Amgen Inc., 5,Celgene Corporation, 5; J. Yeung, None; D. P. Mosher, None; S. Z. Aydın, None; L. Martin, None; A. Masetto, None; S. Keeling, None; O. Ziouzina, None; S. Rohekar, Abbvie, Amgen, Eli-Lily, Janssen, Merck, Novartis, Pfizer, Roche, UCB, 5,Eli-Lily, 8; J. Paschke, None; A. Carapellucci, None; R. G. Lambert, None.

To cite this abstract in AMA style:

Maksymowych WP, Carmona R, Chan J, Yeung J, Mosher DP, Aydın SZ, Martin L, Masetto A, Keeling S, Ziouzina O, Rohekar S, Paschke J, Carapellucci A, Lambert RG. What Is the Impact of Imaging on Diagnostic Ascertainment of Patients Presenting with Undiagnosed Back Pain in Routine Practice and the Impact of Central Reading? Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/what-is-the-impact-of-imaging-on-diagnostic-ascertainment-of-patients-presenting-with-undiagnosed-back-pain-in-routine-practice-and-the-impact-of-central-reading-data-from-the-screening-in-axial-spon/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-the-impact-of-imaging-on-diagnostic-ascertainment-of-patients-presenting-with-undiagnosed-back-pain-in-routine-practice-and-the-impact-of-central-reading-data-from-the-screening-in-axial-spon/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology